Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Cavo M, Dimopoulos MA, San-Miguel J, Jakubowiak AJ, Suzuki K, Yoon SS. et al.
Impact of baseline renal function on efficacy and safety of daratumumab plus bortezomib-melphalan-prednisone (VMP) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).

J Clin Oncol 2018;
36 (Suppl. 15) e20024

Bibliographische Angaben herunterladen

Aufrufen in: